Predictions of growth within cellular therapy may show patient long-term subject recruitment challenges for clinical trials
ExcellThera enters into a manufacturing and collaboration agreement with New York Blood Center for the clinical grade production of ExCellThera’s lead cell therapy product, ECT-001 technology.
CCS: A single source for all of your pre-clinical research program and clinical trials needs from start to finish. Your ideas. Our world-class expertise.